Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults

Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat

NCT00991926 ·Status: COMPLETED

Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects

NCT00909766 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg

NCT05076474 ·Status: COMPLETED ·Phase: NA

Orlistat/Phentermine Versus Placebo/Phentermine

NCT03675191 ·Status: COMPLETED ·Phase: NA

A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects

NCT01597609 ·Status: COMPLETED ·Phase: PHASE1

Orlistat Induced Modulation on the Fatty Acid Composition in Obese Females

NCT01414465 ·Status: COMPLETED ·Phase: NA

Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)

NCT00533481 ·Status: COMPLETED ·Phase: PHASE2

Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults

NCT02706067 ·Status: COMPLETED ·Phase: PHASE4

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

NCT06717425 ·Status: COMPLETED ·Phase: PHASE2

RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity

NCT02529631 ·Status: COMPLETED ·Phase: NA

The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects

NCT01719419 ·Status: WITHDRAWN ·Phase: NA

A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease

NCT05931380 ·Status: COMPLETED ·Phase: PHASE3

A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight

NCT06124807 ·Status: COMPLETED ·Phase: PHASE2

Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

NCT00479492 ·Status: COMPLETED ·Phase: PHASE2

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

NCT01126970 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity

NCT04707313 ·Status: COMPLETED ·Phase: PHASE2

Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects

NCT03041792 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

NCT06230523 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes

NCT00422058 ·Status: COMPLETED ·Phase: PHASE2

RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.

NCT07301437 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

NCT00449202 ·Status: UNKNOWN ·Phase: PHASE2

A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)

NCT04521751 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study Exploring the Supportive Effect of Acarbose in Weight Management

NCT05934110 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

NCT06972459 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.

NCT03856047 ·Status: COMPLETED ·Phase: PHASE2